Pharmacokinetics of the P-gp Inhibitor Tariquidar in Rats After Intravenous, Oral, and Intraperitoneal Administration

BACKGROUND AND OBJECTIVE: P-glycoprotein (P-gp), a transmembrane transporter expressed at the blood–brain barrier, restricts the distribution of diverse central nervous system-targeted drugs from blood into brain, reducing their therapeutic efficacy. The third-generation P-gp inhibitor tariquidar (X...

Descripción completa

Detalles Bibliográficos
Autores principales: Matzneller, Peter, Kussmann, Manuel, Eberl, Sabine, Maier-Salamon, Alexandra, Jäger, Walter, Bauer, Martin, Langer, Oliver, Zeitlinger, Markus, Poeppl, Wolfgang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2018
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6133083/
https://www.ncbi.nlm.nih.gov/pubmed/29616423
http://dx.doi.org/10.1007/s13318-018-0474-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6133083/
https://www.ncbi.nlm.nih.gov/pubmed/29616423
http://dx.doi.org/10.1007/s13318-018-0474-x

Ejemplares similares